MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund said on Thursday it had reached an agreement with Serbia’s Torlak Institute to produce the Sputnik V vaccine against COVID-19 there.
(Reporting by Anton Kolodyazhnyy; Writing by Gabrielle Tétrault-Farber; Editing by Toby Chopra)
